PMC:7558914 / 21673-21875 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"539","span":{"begin":0,"end":18},"obj":"Chemical"}],"attributes":[{"id":"A539","pred":"tao:has_database_id","subj":"539","obj":"MESH:D008775"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Methylprednisolone was the most frequently included corticosteroid in the protocols (13/15 protocols) with high-dose regimens (≥1 mg/kg/day) and a variable duration of treatment (between 3 and 10 days)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T140","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Methylprednisolone was the most frequently included corticosteroid in the protocols (13/15 protocols) with high-dose regimens (≥1 mg/kg/day) and a variable duration of treatment (between 3 and 10 days)."}